Bovine xenograft pericardial patch use for definitive single stage repair of a large esophageal defect: a case report
Name:
s13019-021-01670-0.pdf
Size:
1.377Mb
Format:
PDF
Description:
Final Published Version
Affiliation
Department of Surgery, College of Medicine, University of ArizonaIssue Date
2021
Metadata
Show full item recordPublisher
BioMed Central LtdCitation
Shennib, H., Baribault, M., & Heuser, R. (2021). Bovine xenograft pericardial patch use for definitive single stage repair of a large esophageal defect: A case report. Journal of Cardiothoracic Surgery.Rights
Copyright © The Author(s) 2021. This article is licensed under a Creative Commons Attribution 4.0 International License.Collection Information
This item from the UA Faculty Publications collection is made available by the University of Arizona with support from the University of Arizona Libraries. If you have questions, please contact us at repository@u.library.arizona.edu.Abstract
Background: Large esophageal perforations are challenging and often treated with exclusion or resection. This case demonstrates the feasibility of definitive surgical repair of a large esophageal perforation using large bovine pericardial patch. Case: A patient with missed Boerhaave Syndrome underwent transesophageal echocardiography causing worsening perforation and sepsis. At thoracotomy and faced with a large esophageal defect, a large Bovine pericardial patch was used for repair with omentopexy. The patient recovered promptly and at 8 months was asymptomatic with satisfactory studies. Conclusion: Xenograft pericardium is available and widely used for vascular reconstructions. It’s use for primary repair of large esophageal perforations should be considered. © 2021, The Author(s).Note
Open access journalISSN
1749-8090Version
Final published versionae974a485f413a2113503eed53cd6c53
10.1186/s13019-021-01670-0
Scopus Count
Collections
Except where otherwise noted, this item's license is described as Copyright © The Author(s) 2021. This article is licensed under a Creative Commons Attribution 4.0 International License.